Article
Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition.
Diabetes & metabolism journal - 1 Nov 2023
Lee Ho Gyun, Jung Il Hyeon, Park Byong Seo, Yang Hye Rim, Kim Kwang Kon, Tu Thai Hien, Yeh Jung-Yong, Lee Sewon, Yang Sunggu, Lee Byung Ju, Kim Jae Geun, Nam-Goong Il Seong
Abstract excerpt
BACKGRUOUND: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are currently used to treat patients with diabetes. Previous studies have demonstrated that treatment with SGLT-2 inhibitors is accompanied by altered metabolic phenotypes. However, it has not been investigated whether the hypothalamic circuit participates in the development of the compensatory metabolic phenotypes triggered by the treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
